A randomized phase 1 study demonstrated that patients with kidney cancer who took probiotic supplements of Clostridium butyricum showed an improved response to immunotherapy.
Patients with kidney cancer who took probiotic supplements of Clostridium butyricum had improved response to immunotherapy, according to a randomized phase 1 study.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
